P

Inventor

QIAN DING-QUAN

US48 patents
⚠️ This page may combine multiple inventors who share the name “QIAN DING-QUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

38 patents
US7767675B2Aug 3, 2010

Imidazotriazines and imidazopyrimidines as kinase inhibitors

INCYTE CORP85 citations99
US10214528B2Feb 26, 2019

Bicyclic heterocycles as FGFR4 inhibitors

INCYTE CORP35 citations98
US9890156B2Feb 13, 2018

Bicyclic heterocycles as FGFR4 inhibitors

INCYTE CORP40 citations98
US9533984B2Jan 3, 2017

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP42 citations98
US9382231B2Jul 5, 2016

Bipyrazole derivatives as JAK inhibitors

INCYTE CORP40 citations98
US7776874B2Aug 17, 2010

Amido compounds and their use as pharmaceuticals

INCYTE CORP27 citations96
US7304081B2Dec 4, 2007

Amido compounds and their use as pharmaceuticals

INCYTE CORP42 citations96
US11339149B2May 24, 2022

Heterocyclic compounds as immunomodulators

INCYTE CORP24 citations94
US11014923B2May 25, 2021

Bicyclic heterocycles as FGFR4 inhibitors

INCYTE CORP22 citations94
US11001571B2May 11, 2021

Bipyrazole derivatives as JAK inhibitors

INCYTE CORP15 citations94
US10947230B2Mar 16, 2021

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP26 citations94
US10851105B2Dec 1, 2020

Bicyclic heterocycles as FGFR4 inhibitors

INCYTE CORP27 citations94
US10806785B2Oct 20, 2020

Immunomodulator compounds and methods of use

INCYTE CORP32 citations94
US10800768B2Oct 13, 2020

Heterocyclic compounds as immunomodulators

INCYTE CORP30 citations94
US10738048B2Aug 11, 2020

Bicyclic heterocycles as FGFR4 inhibitors

INCYTE CORP28 citations94
US10435392B2Oct 8, 2019

Bipyrazole derivatives as JAK inhibitors

INCYTE CORP18 citations94
US9527835B2Dec 27, 2016

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP25 citations94
US9493450B2Nov 15, 2016

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP26 citations94
US9266892B2Feb 23, 2016

Fused pyrazoles as FGFR inhibitors

INCYTE CORP40 citations94
US7683060B2Mar 23, 2010

Triazolotriazines as kinase inhibitors

INCYTE CORP25 citations92
US11673883B2Jun 13, 2023

Heterocyclic compounds as immunomodulators

INCYTE CORP12 citations86
US11667635B2Jun 6, 2023

Bicyclic heterocycles as FGFR4 inhibitors

INCYTE CORP7 citations86
US11591318B2Feb 28, 2023

Bipyrazole derivatives as JAK inhibitors

INCYTE CORP6 citations86
US9957229B2May 1, 2018

Amido compounds and their use as pharmaceuticals

INCYTE CORP4 citations84
US11673894B2Jun 13, 2023

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

INCYTE CORP4 citations74
US7915408B2Mar 29, 2011

Triazolotriazines as kinase inhibitors

INCYTE CORP6 citations74
US11905275B2Feb 20, 2024

Bipyrazole derivatives as JAK inhibitors

INCYTE CORP2 citations73
US10738052B2Aug 11, 2020

Imidazotriaines and imidazopyrimidines as kinase inhibitors

INCYTE CORP3 citations73
US11851426B2Dec 26, 2023

Bicyclic amines as CDK2 inhibitors

INCYTE CORP3 citations72
US11472791B2Oct 18, 2022

Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors

INCYTE CORP7 citations72
US12247020B2Mar 11, 2025

Bipyrazole derivatives as JAK inhibitors

INCYTE CORP0 citations63
US12084449B2Sep 10, 2024

Imidazotriazines and imidazopyrimidines as kinase inhibitors

INCYTE CORP0 citations63
US11261191B2Mar 1, 2022

Imidazotriaines and imidazopyrimidines as kinase inhibitors

INCYTE CORP0 citations63
US11981671B2May 14, 2024

Bicyclic pyrazolyl amines as CDK2 inhibitors

INCYTE CORP2 citations62
US11976073B2May 7, 2024

Bicyclic amines as CDK2 inhibitors

INCYTE CORP2 citations62
US12466828B2Nov 11, 2025

Bicyclic amines as CDK2 inhibitors

INCYTE CORP0 citations60
US10513493B2Dec 24, 2019

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP0 citations52
US9670154B2Jun 6, 2017

Amido compounds and their use as pharmaceuticals

INCYTE CORP0 citations52

ZHUO JINCONG

4 patents

YAO WENQING

4 patents

INCYTE HOLDINGS CORP

1 patent

ZHANG COLIN

1 patent